GLI1-Mediated transcription inhibitor
| 496794-70-8 Basic information More.. |
Product Name: | GLI1-Mediated transcription inhibitor | Synonyms: | GLI1-Mediated transcription inhibitor;BenzaMide, N-[4-chloro-3-[6-(diMethylaMino)-1H-benziMidazol-2-yl]phenyl]-3,5-diMethoxy-;HhAntag;N-(4-chloro-3-(5-(diMethylaMino)-1H-benzo[d]iMidazol-2-yl)phenyl)-3,5-diMethoxybenzaMide;N-[4-Chloro-3-[5-(dimethylamino)-1H-benzimidazol-2-yl]phenyl]-3,5-dimethoxybenzamide;N-(4-Chloro-3-(6-(dimethylamino)-1H-benzo[d]imidazol-2-yl)phenyl)-3,5-dimethoxybenzamide;N-[4-chloro-3-[6-(dimethylamino)-1H-benzimidazol-2-yl]phenyl]-3;104683 | CAS: | 496794-70-8 | MF: | C24H23ClN4O3 | MW: | 450.92 | EINECS: | | Mol File: | 496794-70-8.mol |  |
GLI1-Mediated transcription inhibitor manufacturers
- HhAntag
-
- US $44.00-188.00 / mg
- 2025-05-08
- CAS:496794-70-8
- Min. Order:
- Purity: 95.73%
- Supply Ability: 10g
|
496794-70-8
Recommend Suppliers |
|
Tag:
496794-70-8
|